Roquefort Investments PLC Results of General Meeting (4696V)

TIDMROQ

RNS Number : 4696V

Roquefort Investments PLC

13 December 2021

Roquefort Investments plc

("Roquefort Investments" or the "Company")

Results of General Meeting

Roquefort Investments (LSE:ROQ), the London listed investment company established to acquire businesses focused on early-stage opportunities in the medical biotechnology sector , is pleased to announce that at the Company's General Meeting held earlier today, all resolutions proposed were duly passed.

The resolutions were put to shareholders via a poll, the results of which were as follows:

 
                                      Poll Results 
 Resolution           For   Against   Abstain   Discretionary       Total 
               ----------  --------  --------  --------------  ---------- 
 1    Shares    1,800,000         -         -               -   1,800,000 
     --------  ----------  --------  --------  --------------  ---------- 
      %              100%         -         -               -        100% 
     --------  ----------  --------  --------  --------------  ---------- 
 2    Shares    1,800,000         -         -               -   1,800,000 
     --------  ----------  --------  --------  --------------  ---------- 
      %              100%         -         -               -        100% 
     --------  ----------  --------  --------  --------------  ---------- 
 3    Shares    1,800,000         -         -               -   1,800,000 
     --------  ----------  --------  --------  --------------  ---------- 
      %              100%         -         -               -        100% 
     --------  ----------  --------  --------  --------------  ---------- 
 4    Shares    1,800,000         -         -               -   1,800,000 
     --------  ----------  --------  --------  --------------  ---------- 
      %              100%         -         -               -        100% 
     --------  ----------  --------  --------  --------------  ----------

The total number of ordinary shares in issue on 9 December 2021, the deadline for casting votes by proxy in advance of the General Meeting, was 36,900,000 shares. 4.88% of voting capital was instructed in respect of the resolutions put to the Genaral Meeting.

Enquiries:

 
 Roquefort Investments plc 
                                          +44 (0)20 3290 
 Stephen West (Chairman)                            9339 
 Buchanan (Public Relations) 
  Ben Romney / Jamie Hooper 
                                          +44 (0)20 7466 
  Optiva Securities Limited (Broker)                5000 
                                          +44 (0)20 3411 
 Christian Dennis                                   1881

For further information on Roquefort Investments, please visit www.roquefortinvest.com and @roquefortinvest on Twitter.

LEI: 254900P4SISIWOR9RH34

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ROMBXBDDLBBDGBX

(END) Dow Jones Newswires

December 13, 2021 08:19 ET (13:19 GMT)

Roquefort Therapeutics (LSE:ROQ)
Historical Stock Chart
From May 2024 to Jun 2024